Hemodialysis versus Renal Transplantation: A Comparative Analysis of Cardiovascular Outcomes among End-Stage Renal Disease Patients unveiling the Safer Pathway

Objective Individuals with End-Stage Renal Disease (ESRD) experience a heightened risk of cardiovascular morbidity and mortality, often linked to the hemodynamic instability and chronic physiological stressors inherent due to renal replacement therapies (RRT). The objective of this study was to evaluate the impact of hemodialysis (HD) and renal transplantation (RT) on cardiac health by comparing their transthoracic echocardiographic (TTE) parameters to those of a control group. Methodology The study analyzed records from the Renal Transplant and Dialysis unit of Nephrology department of Dow University Hospital (DUH). The cohort consisted of 104 subjects: 37.5% (n = 39) were HD, 38.5% (n = 40) had received RT and 24% (n = 25) were controls. TTE data were recruited for each participant and statistically analyzed using R Studio. Results The mean age of the study population was 38 ± 13 years, with a male predominance (79.86%). The mean ejection fraction (EF) for HD subjects (55.64 ± 13%) was found to be notably lower than in RT (61.25 ± 7%) and controls (64.4 ± 2%). Both systolic (32.2 mm) and diastolic (46.4 mm) left ventricular diameters were enlarged among HD subjects in comparison to controls (29.8 mm and 43.9 mm, respectively), while the right ventricular diameter was diminished. Furthermore, 62.02% (n = 49) of the entire subjects showed both tricuspid and mitral regurgitation, with HD subjects accounting for 63.26% (n = 31) of these cases. Conclusion The data demonstrates a higher incidence of cardiac abnormalities including reduced EF and adverse ventricular and valvular changes among HD subjects. These findings underscore the importance of exploring long-term renal replacement strategies that mitigate cardiovascular risk, suggesting that RT could be a more favorable option to improve both cardiac and renal outcomes among subjects with ESRD.